BVDV vaccine
AssigneeIntervet Inc.
InventorsMartin Beer, Ilona Reimann, Patricia Koenig
Life of this patent
Estimating the term…
Abstract
The present invention relates to BVD virus and to its uses, to vaccines and combination vaccines comprising such a virus, their use as a medicament, their use in the treatment of Bovine Viral Diarrhea and to methods for the preparation of such vaccines.
Claims16
A combination vaccine for the protection against Bovine Viral Diarrhea Virus (BVDV) that comprises a first live attenuated BVDV, a second live attenuated BVDV, and a pharmaceutically acceptable carrier;
- wherein the first BVDV and the second BVDV are either both Type 1 BVDVs or both Type 2 BVDVs;
- wherein the first BVDV and the second BVDV each comprise a BVDV E2 gene;
- and
- wherein when the first BVDV and the second BVDV are both Type 1 BVDVs, the E2 gene of the second BVDV is replaced by a BVDV E2 gene of a Type 2 BVDV;
- and wherein when the first BVDV and the second BVDV are both Type 2 BVDVs, the E2 gene of the second BVDV is replaced by a BVDV E2 gene of a Type 1 BVDV.
A combination vaccine for the protection against Bovine Viral Diarrhea Virus (BVDV) that comprises a first live attenuated BVDV, a second live attenuated BVDV, and a pharmaceutically acceptable carrier;
- wherein the first BVDV and the second BVDV are either both Type 1 BVDVs or both Type 2 BVDVs;
- wherein the first BVDV and the second BVDV each comprise a BVDV E1 gene and a BVDV E2 gene;
- and
- wherein when the first BVDV and the second BVDV are both Type 1 BVDVs, both the BVDV E2 gene and the BVDV E1 gene of the second BVDV are replaced by a BVDV E2 gene and a BVDV E1 gene of a Type 2 BVDV;
- and wherein when the first BVDV and the second BVDV are both Type 2 BVDVs, both the E2 and the E1 gene of the second BVDV is replaced by a BVDV E2 and BVDV E1 gene of a Type 1 BVDV.
Dependencies are inferred from the claim text.